Your browser doesn't support javascript.
loading
Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
Bian, Yu; Li, Xin; Li, Xin; Ju, Jiaming; Liang, Hangfei; Hu, Xueling; Dong, Lei; Wang, Ning; Li, Jiamin; Zhang, Yan; Yang, Baofeng.
Affiliation
  • Bian Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: 841945358@qq.com.
  • Li X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China; Northern Translational Medicine Research and Cooperation Center, He
  • Li X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: 953204620@qq.com.
  • Ju J; Northern Translational Medicine Research and Cooperation Center, Heilongjiang Academy of Medical Sciences, Harbin Medical University, Harbin, Heilongjiang 150081, PR China. Electronic address: 911383845@qq.com.
  • Liang H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: 928126128@qq.com.
  • Hu X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: 596423749@qq.com.
  • Dong L; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: 785749485@qq.com.
  • Wang N; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China; Northern Translational Medicine Research and Cooperation Center, He
  • Li J; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China; Northern Translational Medicine Research and Cooperation Center, He
  • Zhang Y; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China. Electronic address: zhangyan@ems.hrbmu.edu.cn.
  • Yang B; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, PR China; Northern Translational Medicine Research and Cooperation Center, He
Biomed Pharmacother ; 117: 109176, 2019 Sep.
Article in En | MEDLINE | ID: mdl-31387185
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signal Transduction / Lipid Metabolism / AMP-Activated Protein Kinases / Lipids / Hypolipidemic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Country/Region as subject: Asia Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Signal Transduction / Lipid Metabolism / AMP-Activated Protein Kinases / Lipids / Hypolipidemic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans / Male Country/Region as subject: Asia Language: En Year: 2019 Type: Article